VVOS (STOCKS)
Vivos Therapeutics, Inc. Common Stock
$0.577300
+0.005300 (+0.93%)
Prev close: $0.572000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- R. Kirk Huntsman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8.09M
- Employees
- 109
- P/E (TTM)
- -0.25
- P/B (TTM)
- -6.84
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.52 | $-0.46 | -0.0576 | -12.46% |
|
Dec 2025 (Q4)
|
$-0.58 | $-0.49 | -0.0870 | -17.65% |
|
Sep 2025 (Q3)
|
$-0.49 | $-0.52 | +0.0302 | +5.81% |
|
Jun 2025 (Q2)
|
$-0.55 | $-0.39 | -0.1573 | -40.06% |
Financial Statements
| Revenues | $19.57M |
| Benefits Costs and Expenses | $44.69M |
| Cost Of Revenue | $7.47M |
| Costs And Expenses | $44.69M |
| Gross Profit | $12.09M |
| Operating Expenses | $34.69M |
| Depreciation and Amortization | $1.59M |
| Other Operating Expenses | $33.00M |
| Operating Income/Loss | -$22.60M |
| Income/Loss From Continuing Operations After Tax | -$25.12M |
| Income/Loss From Continuing Operations Before Tax | -$25.12M |
| Net Income/Loss | -$25.12M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$129.00K |
| Net Income/Loss Attributable To Parent | -$24.99M |
| Net Income/Loss Available To Common Stockholders, Basic | -$25.05M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $60.00K |
| Preferred Stock Dividends And Other Adjustments | $60.00K |
| Basic Earnings Per Share | -$2.14 |
| Diluted Earnings Per Share | -$2.14 |
| Basic Average Shares | 35,401,420 |
| Diluted Average Shares | 35,401,420 |
| Assets | $25.04M |
| Current Assets | $4.82M |
| Noncurrent Assets | $20.22M |
| Fixed Assets | $3.53M |
| Intangible Assets | $3.84M |
| Other Non-current Assets | $12.86M |
| Liabilities | $26.31M |
| Current Liabilities | $17.94M |
| Accounts Payable | $2.00M |
| Other Current Liabilities | $15.94M |
| Noncurrent Liabilities | $8.37M |
| Long-term Debt | $617.00K |
| Other Non-current Liabilities | $7.76M |
| Equity | -$1.27M |
| Equity Attributable To Noncontrolling Interest | -$129.00K |
| Equity Attributable To Parent | -$1.14M |
| Liabilities And Equity | $25.04M |
| Net Cash Flow From Operating Activities | -$17.48M |
| Net Cash Flow From Operating Activities, Continuing | -$17.48M |
| Net Cash Flow From Investing Activities | -$7.42M |
| Net Cash Flow From Investing Activities, Continuing | -$7.42M |
| Net Cash Flow From Financing Activities | $20.67M |
| Net Cash Flow From Financing Activities, Continuing | $20.67M |
| Net Cash Flow | -$4.23M |
| Net Cash Flow, Continuing | -$4.23M |
| Comprehensive Income/Loss | -$25.12M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$25.12M |
| Other Comprehensive Income/Loss | $0.00 |